Masahide Sawada

10PUBLICATIONS
11CO-AUTHORS
Nanoelectromechanical systemsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 12, 2024
Melanoma incidence on the non-weight-bearing areas of the sole.

Kazuki Furudate, Junji Kato, Kohei Horimoto

|Sep 02, 2023
Effects of temozolomide on tumor mutation burden and microsatellite instability in melanoma cells.

Masahide Sawada, Tokimasa Hida, Takafumi Kamiya

|Aug 01, 2020
Usefulness of neuron-specific enolase as a serum marker of metastatic melanoma.

Sayuri Sato, Junji Kato, Masahide Sawada

|Oct 05, 2019
Durable response after cessation of anti-programmed death 1 therapy in four melanoma patients.

Toshiya Handa, Junji Kato, Yasuyuki Sumikawa

|May 16, 2019
Cutaneous apocrine carcinoma with elevated serum cytokeratin 19 fragment 21-1 (CYFRA 21-1).

Mao Fujioka, Junji Kato, Yasuyuki Sumikawa

|Feb 14, 2019
Efficacy of combined radiotherapy and anti-programmed death 1 therapy in acral and mucosal melanoma.

Junji Kato, Tokimasa Hida, Masanori Someya

Pageof 2